The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes.

Cancer Res Treat · 2019 · PMC6473277 · PMID 30134648

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

showed a trendp=0.063so close (0.05 < p ≤ 0.1)

PELP1 hi cases also showed a trend towards worse BCSS (log-rank=3.446, p=0.063).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.